Cite
HARVARD Citation
Navada, S. et al. (n.d.). 89 A PHASE I STUDY OF THE COMBINATION OF AZACITIDINE AND ORAL RIGOSERTIB IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) OR ACUTE MYELOID LEUKEMIA (AML). Leukemia research. 39 (1), pp. S45-. [Online].